Genetic Variants in PNPLA3 and Risk of Non-Alcoholic Fatty Liver Disease in a Han Chinese Population

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Peng, Xian E ^a   Wu, Yun Li ^a   Lin, Shao Wei ^a   Lu, Qing Qing ^a   Hu, Zhi Jian ^a   Lin, Xu ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PHOSPHOLIPASE;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRINKING BEHAVIOR; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PNPLA3 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TEA;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPASE; LIVER; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; TEA;

EID: 84870622854     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050256     Document Type: Article

References (49)

1. Sookoian S, Castano GO, Burgueno AL, Fernandez Gianotti T, Rosselli MS, et al. (2009) A nonsynonymous gene variant in adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J Lipid Res 50(10): 2111-2116.
2. Barshop NJ, Sirlin CB, Schwimmer JB, Lavine JE, (2008) Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. Aliment Pharmacol Ther 28: 13-24.
3. Hoekstra M, Li Z, Kruijt JK, Van Eck M, Van Berkel TJ, et al. (2010) The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status. J Hepatol 52: 244-251.
4. Suzuki A, Lindor K, St Saver J, Lymp J, Mendes F, et al. (2005) Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 43: 1060-1066.
5. Harrison SA, Day CP, (2007) Benefits of lifestyle modification in NAFLD. Gut 56: 1760-1769.
6. Schwimmer JB, Celedon MA, Lavine JE, Salem R, Campbell N, et al. (2009) Heritability of nonalcoholic fatty liver disease. Gastroenterology 136: 1585-1592.
7. Speliotes EK, Yerges-Armstrong LM, Wu J, Hernaez R, Kim LJ, et al. (2011) Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 7: e1001324.
8. Song J, da Costa KA, Fischer LM, Kohlmeier M, Kwock L, et al. (2005) Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD). FASEB J 19: 1266-1271.
9. Chen S, Li Y, Li S, Yu C, (2008) A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-to-hip ratio. J Gastroenterol Hepatol 23: 1415-1418.
10. Sookoian S, Castano G, Gianotti TF, Gemma C, Pirola CJ, (2009) Polymorphisms of MRP2 (ABCC2) are associated with susceptibility to nonalcoholic fatty liver disease. J Nutr Biochem 20: 765-770.
11. Sookoian S, Castano G, Gianotti TF, Gemma C, Rosselli MS, et al. (2008) Genetic variants in STAT3 are associated with nonalcoholic fatty liver disease. Cytokine 44: 201-206.
12. Huang Y, He S, Li JZ, Seo YK, Osborne TF, et al. (2010) A feed-forward loop amplifies nutritional regulation of PNPLA3. Proc Natl Acad Sci U S A 107: 7892-7897.
13. He S, McPhaul C, Li JZ, Garuti R, Kinch L, et al. (2010) A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 285: 6706-6715.
14. Trepo E, Gustot T, Degre D, Lemmers A, Verset L, et al. (2011) Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. J Hepatol 55(4): 906-912.
15. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, et al. (2008) Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40: 1461-1465.
16. Yuan X, Waterworth D, Perry JR, Lim N, Song K, et al. (2008) Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet 83: 520-528.
17. Rotman Y, Koh C, Zmuda JM, Kleiner DE, Liang TJ, (2010) The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 52: 894-903.
18. Santoro N, Kursawe R, D'Adamo E, Dykas DJ, Zhang CK, et al. (2010) A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology 52: 1281-1290.
19. Speliotes EK, Butler JL, Palmer CD, Voight BF, Hirschhorn JN, (2010) PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology 52: 904-912.
20. Wagenknecht LE, Palmer ND, Bowden DW, Rotter JI, Norris JM, et al. (2011) Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study. Liver Int 31: 412-416.
21. Li X, Zhao Q, Wu K, Fan D, (2011) I148M variant of PNPLA3 confer increased risk for nonalcoholic fatty liver disease not only in European population, but also in Chinese population. Hepatology 54: 2275.
22. Li Y, Xing C, Cohen JC, Hobbs HH, (2012) Genetic variant in PNPLA3 is associated with nonalcoholic fatty liver disease in China. Hepatology 55: 327-328.
23. Peng XE, Wu YL, Lu QQ, Hu ZJ, Lin X, (2012) Two genetic variants in FABP1 and susceptibility to non-alcohol fatty liver disease in a Chinese population. Gene 500(1): 54-58.
24. Zeng MD, Fan JG, Lu LG, Li YM, Chen CW, et al. (2008) Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J Dig Dis 9: 108-112.
25. Alberti KG, Zimmet P, Shaw J, (2005) The metabolic syndrome-a new worldwide definition. Lancet 366: 1059-1062.
26. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
27. Lake SL, Lyon H, Tantisira K, Silverman EK, Weiss ST, et al. (2003) Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 55: 56-65.
28. Hosmer DW, Lemeshow S, (1992) Confidence interval estimation of interaction. Epidemiology 3: 452-456.
29. Purcell S, Cherny SS, Sham PC, (2003) Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19: 149-150.
30. Foppa I, Spiegelman D, (1997) Power and sample size calculations for case-control studies of gene-environment interactions with a polytomous exposure variable. Am J Epidemiol 146: 596-604.
31. Lake AC, Sun Y, Li JL, Kim JE, Johnson JW, et al. (2005) Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members. J Lipid Res 46: 2477-2487.
32. Baulande S, Lasnier F, Lucas M, Pairault J, (2001) Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage. J Biol Chem 276: 33336-33344.
33. Polson DA, Thompson MP, (2004) Macronutrient composition of the diet differentially affects leptin and adiponutrin mRNA expression in response to meal feeding. J Nutr Biochem 15: 242-246.
34. Liu YM, Moldes M, Bastard JP, Bruckert E, Viguerie N, et al. (2004) Adiponutrin: A new gene regulated by energy balance in human adipose tissue. J Clin Endocrinol Metab 89: 2684-2689.
35. Romeo S, Sentinelli F, Dash S, Yeo GS, Savage DB, et al. (2010) Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent. Int J Obes (Lond) 34: 190-194.
36. Kershaw EE, Hamm JK, Verhagen LA, Peroni O, Katic M, et al. (2006) Adipose triglyceride lipase: function, regulation by insulin, and comparison with adiponutrin. Diabetes 55: 148-157.
37. Jenkins CM, Mancuso DJ, Yan W, Sims HF, Gibson B, et al. (2004) Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem 279: 48968-48975.
38. Calvo RM, Obregon MJ, (2009) Tri-iodothyronine upregulates adiponutrin mRNA expression in rat and human adipocytes. Mol Cell Endocrinol 311: 39-46.
39. Chalasani N, Guo X, Loomba R, Goodarzi MO, Haritunians T, et al. (2010) Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease. Gastroenterology 139(5): 1567-1576.
40. Miyoshi H, Perfield JW 2nd, Obin MS, Greenberg AS (2008) Adipose triglyceride lipase regulates basal lipolysis and lipid droplet size in adipocytes. J Cell Biochem 105: 1430-1436.
41. Romeo S, Sentinelli F, Cambuli VM, Incani M, Congiu T, et al. (2010) The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. J Hepatol 53: 335-338.
42. Giudice EM, Grandone A, Cirillo G, Santoro N, Amato A, et al. (2011) The Association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat. PLoS One 6: e27933.
43. Kantartzis K, Peter A, Machicao F, Machann J, Wagner S, et al. (2009) Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes 58: 2616-2623.
44. Sano M, Kuroi N, Nakayama T, Sato N, Izumi Y, et al. (2005) Association study of calcitonin-receptor-like receptor gene in essential hypertension. Am J Hypertens 18: 403-408.
45. Lehman DM, Fu DJ, Freeman AB, Hunt KJ, Leach RJ, et al. (2005) A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans. Diabetes 54: 1214-1221.
46. Euskirchen G, Royce TE, Bertone P, Martone R, Rinn JL, et al. (2004) CREB binds to multiple loci on human chromosome 22. Mol Cell Biol 24: 3804-3814.
47. Moore JH, Williams SM, (2002) New strategies for identifying gene-gene interactions in hypertension. Ann Med 34: 88-95.
48. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, et al. (2006) Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 296: 1255-1265.
49. Imai K, Nakachi K, (1995) Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 310: 693-696.